Masanobu Azuma

484 citations
22 papers · 395 indexed · h-index 9
Topics
Herpesvirus Infections and Treatments (10 papers)Virus-based gene therapy research (5 papers)Cytomegalovirus and herpesvirus research (5 papers)

In The Last Decade

Masanobu Azuma

22 papers receiving 372 citations

Peers

Masanobu Azuma
Comparison fields: 5 of 59
  • Epidemiology 244
  • Immunology 131
  • Genetics 80
  • Molecular Biology 62
  • Biochemistry 60
Replace Annette Meyer with:
Annette Meyer United States
Melissa C. Long Canada
Preeti Verma India
E. C. Herrmann United States
Shih-Tung Liu Taiwan
Qingjiao Liao China
Ahmed Atef Mesalam Egypt
Wenchun Fan China
Amit Raychoudhuri India
Sun-Young Chang South Korea
Masanobu Azuma relative to Annette Meyer United States Annette Meyer's profile →
Citations per field
00.5×2.8×
Annette Meyer · 1×
Citations per year

Countries citing papers authored by Masanobu Azuma

Since Specialization
Citations

This map shows the geographic impact of Masanobu Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanobu Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanobu Azuma more than expected).

Fields of papers citing papers by Masanobu Azuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanobu Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanobu Azuma. The network helps show where Masanobu Azuma may publish in the future.

Co-authorship network of co-authors of Masanobu Azuma

This figure shows the co-authorship network connecting the top 25 collaborators of Masanobu Azuma. A scholar is included among the top collaborators of Masanobu Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanobu Azuma. Masanobu Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 32
3 43
4 35
5 27
6 58
7 5
8 81
9 8
10 4
11 2
12 22
13 9
14 3
15 1
16 6
17 7
18 7
19 4
20 2

About Masanobu Azuma

Masanobu Azuma is a scholar working on Immunology, Biological Psychiatry and Animal Science and Zoology, having authored 22 papers that have together received 395 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (10 papers), Virus-based gene therapy research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Biochemistry (60 citations), Virology (35 citations) and Epidemiology (244 citations). Masanobu Azuma has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Tatsuo Suzutani, Itsuro Yoshida, Masahiro Ogasawara, Yukihiro Nishiyama, Masayuki Saijo, Shin Koyano, Minoru Takada, Kazuya Hayashi, Motoyuki Mori and Keizo Hosokawa. Their work appears in journals such as Journal of Virology, Journal of Bacteriology and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026